
S.O.S. Drug Policy Newsletter & Legislative Updates

Youth Marijuana Addiction Increased Following Recreational Marijuana Legalization in California
A new study examined cannabis use disorder among more than 637,000 adolescents in California, finding that previously declining rates changed course following recreational marijuana legalization.
Read more
DEA Moves to Temporarily Schedule 7-Hydroxymitragynine (7-OH) and Related Substances
The U.S. Drug Enforcement Administration (DEA) has issued two Notices of Intent to temporarily place 7-hydroxymitragynine (7-OH) and three related substances into Schedule I of the Controlled Substances Act (CSA). This temporary scheduling includes: 7-Hydroxymitragynine (7-OH), Mitragynine pseudoindoxyl (MP), Dihydro-7-hydroxymitragynine (MGM-15), and 9-fluoro derivative of 7-hydroxymitragynine (MGM-16). These substances exhibit psychoactive, opioid-like effects, have unpredictable potency, no currently accepted medical Continue Reading
Read more
Children Should Never Be the Cost of Marijuana Commercialization
A new study analyzing 25 years of poison control center data found pediatric marijuana exposures have increased dramatically since 2009. Researchers report more than a 6,000% increase among children under age six, raising important questions about cannabis commercialization, child safety, and the need for stronger public health protections.
Read more






